Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Home
Eric Rosenthal Reports
Eric Rosenthal Reports
Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
Eric T. Rosenthal
-
March 5, 2019
Dr. Brawley Goes to Baltimore?and Washington
Jose Baselga Resigns as Co-Editor-in-Chief of Cancer Discovery
Professional Societies Disclose Their Disclosure Policies, But Why Won?t Some Discuss Them?
Otis Brawley Discusses Life After Leaving the American Cancer Society
How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s...
Eric T. Rosenthal
-
October 9, 2018
How a Hollywood-and-Scientist Dream Team Created a New Paradigm in Collaborative...
Eric T. Rosenthal
-
September 22, 2018
Mike Caligiuri Discusses Upcoming AACR Meeting, Cancer Health Equality, and Sudden...
Eric T. Rosenthal
-
April 12, 2018
Why Academia Wasn’t Ready to Build Big Data Systems – A...
Eric T. Rosenthal
-
April 10, 2018
Eric Rosenthal Reports | A Personal Remembrance of Two Giants of...
Eric T. Rosenthal
-
April 3, 2018
LATEST
ASH 2019: Brentuximab Vedotin in Combination with Nivolumab in Frontline and R/R Hodgkin Lymphoma
Editorial Team
-
December 8, 2019
ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and Simplify Treatment
Peter Hofland, Ph.D
-
December 8, 2019
Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes
Peter Hofland, Ph.D
-
December 8, 2019
